Bayer AG Sponsored ADR logo

Bayer AG Sponsored ADR (BAYRY)

Market Closed
3 Jun, 20:00
OTC PINK OTC PINK
$
9. 9200
+0.04
+0.4%
$
41.5B Market Cap
- P/E Ratio
10.54% Div Yield
232,314 Volume
0 Eps
$ 9.88
Previous Close
Add Transaction
Day Range
9.85 10.05
Year Range
7.03 14.85
Want to track BAYRY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock

Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Secondary Stroke Prevention Transcript

Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Secondary Stroke Prevention Transcript

Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Secondary Stroke Prevention Transcript

Seekingalpha | 3 months ago
Bayer's Asundexian Shows 26% Stroke Reduction in Late-Stage Study

Bayer's Asundexian Shows 26% Stroke Reduction in Late-Stage Study

Bayer presents positive data on asundexian, which shows superior efficacy with no added bleeding risk, boosting hopes for regulatory approval.

Zacks | 3 months ago
Are Medical Stocks Lagging Bayer (BAYRY) This Year?

Are Medical Stocks Lagging Bayer (BAYRY) This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and Align Technology (ALGN) have performed compared to their sector so far this year.

Zacks | 3 months ago
Bayer Aktiengesellschaft (BAYRY) is a Top-Ranked Value Stock: Should You Buy?

Bayer Aktiengesellschaft (BAYRY) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 4 months ago
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock

Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 months ago
Bayer Aktiengesellschaft (BAYRY) is a Great Momentum Stock: Should You Buy?

Bayer Aktiengesellschaft (BAYRY) is a Great Momentum Stock: Should You Buy?

Does Bayer Aktiengesellschaft (BAYRY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 4 months ago
Best Value Stocks to Buy for January 21st

Best Value Stocks to Buy for January 21st

BNPQY, BAYRY and DLAKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 21, 2026.

Zacks | 4 months ago
Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case

Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case

BAYRY jumps 6.4% after the Supreme Court agrees to review the Durnell Roundup case, a key test of federal preemption in glyphosate litigation.

Zacks | 4 months ago
Supreme Court to hear Bayer's appeal to block thousands of Roundup weedkiller lawsuits

Supreme Court to hear Bayer's appeal to block thousands of Roundup weedkiller lawsuits

Bayer is arguing that consumers should not be able to sue it under state law for failing to warn that Roundup increases cancer risk because the Environmental Protection Agency has found no such risk and requires no such warning.

Nypost | 4 months ago
US Supreme Court to hear Bayer's bid to curb Roundup cases

US Supreme Court to hear Bayer's bid to curb Roundup cases

The U.S. Supreme Court agreed on Friday to hear Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.

Reuters | 4 months ago
Bayer Stock Jumps on Nubeqa Outlook, Presents Pharma Strategy

Bayer Stock Jumps on Nubeqa Outlook, Presents Pharma Strategy

BAYRY jumps 6.6% after partner Orion said Nubeqa sales tied to Bayer could top ???1B long term.

Zacks | 4 months ago
Loading...
Load More